$CROX

Rees Andrew sold $3.9M of CROX (indirect holdings)

Rees Andrew (Chief Executive Officer) sold 32,688 indirectly-held shares of Crocs, Inc. (CROX) at an average of $118.09 ($116.97–$119.11, $3.86M total) across 3 trades on 2026-06-05.

Original reporting
SEC EDGAR · Rees Andrew
Published Jun 9, 2026, 10:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 9, 2026, 10:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CROX
Neutral
medium confidence
Mentioned
$CROX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CROXNeutralLow
01

Why it matters

Traders may treat the disclosure as a modest sentiment datapoint, but without any accompanying company-specific fundamental news, it is unlikely to drive sustained repricing.

02

Market read

A ~$3.86M CEO share sale is newly disclosed, but the filing alone typically has limited impact absent other catalysts.

03

What to watch

The article doesn’t state whether the CEO’s broader holdings changed materially beyond this sale, nor does it provide context on compensation/option exercises that could offset selling.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-09; transactions dated 2026-06-05.

Background

The article is an SEC EDGAR Form 4 disclosure of an insider (CEO) open-market sale of Crocs shares.

Company-level read

Ticker impact

$CROXNeutralMedium confidence
Context

Crocs CEO Rees Andrew sold about 32,688 shares in open-market transactions totaling ~$3.86M, disclosed via SEC Form 4.

Expected impact

Likely limited/short-lived impact; watch for follow-through only if selling accelerates or coincides with other negative disclosures.

Evidence & confidence

The filing is a primary-source insider transaction, but the article provides no accompanying earnings/guidance, legal, or operational change—so the signal is mostly sentiment/positioning rather than new fundamentals.

Market effects

Minimal; single-company insider sale without sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs; absence of a 10b5-1 plan does not necessarily imply negative expectations.

Key entities

  • Crocs, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Rees Andrew

    CEO and officer/director who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NKEMed

Nike’s Weak First Quarter Report Ripples Across Footwear Sector

Nike reported weaker-than-expected Q1 sales and announced layoffs, causing its shares to drop 6.6% to $32.84. Competitors like Adidas and Puma saw mixed reactions, while other footwear brands and retailers experienced varied share price movements. Retailers such as Academy Sports + Outdoors and Dick’s Sporting Goods saw gains.

$CROXMedAI 8/10

Crocs sues Five Below, alleging they copied the famous clogs

Crocs and Jibbitz Charms sued Five Below, alleging trademark and patent infringement for selling clogs and charms resembling Crocs' products. The lawsuit seeks damages and a permanent injunction. Five Below's net sales rose 27% year-over-year to $344 million by August, with 101 new stores opened.

$CROXMed

Crocs Sues Five Below Over Alleged Knockoff Clogs and Charms

Crocs sued Five Below for allegedly infringing on its patents and trademarks with the sale of its Juniors Charm Clog. The lawsuit, filed in Colorado, claims Five Below's clogs and charms mimic Crocs' designs, misleading consumers. Crocs seeks damages, a permanent injunction, and destruction of infringing inventory. Five Below's clogs retail for $7, while Crocs' Kids Classic Clog sells for $39.99.

$CROXMed

Crocs and Five Below are in a legal fight over a $7 shoe

Crocs is suing Five Below, alleging that its clogs and charms infringe on Crocs' trademarks and patents. The lawsuit seeks damages, a halt to sales, and destruction of inventory. Five Below reported strong financial results, with net sales up 27% and net income over $344 million. Crocs generates over $4 billion in annual sales.

$CROXMedAI 8/10

Crocs sues Five Below, alleging they copied the famous clogs

Crocs has sued Five Below, alleging trademark and patent infringement by selling clogs and accessories resembling Crocs' products. The lawsuit, filed in Colorado, seeks damages and a permanent injunction. Five Below's net sales increased over 27% year-over-year, with net income of $344 million as of August, according to its earnings report.